RNF26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.582800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.089400E-01
Normal-vs-Stage2
7.914000E-01
Normal-vs-Stage3
1.806220E-01
Normal-vs-Stage4
9.621000E-01
Stage1-vs-Stage2
7.532400E-01
Stage1-vs-Stage3
1.729630E-01
Stage1-vs-Stage4
6.956600E-01
Stage2-vs-Stage3
7.875600E-02
Stage2-vs-Stage4
7.010600E-01
Stage3-vs-Stage4
2.782800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.562200E-01
Normal-vs-AfricanAmerican
6.371200E-01
Normal-vs-Asian
7.619000E-01
Caucasian-vs-AfricanAmerican
8.560200E-01
Caucasian-vs-Asian
9.175200E-01
AfricanAmerican-vs-Asian
9.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.259800E-01
Normal-vs-Female
9.048400E-01
Male-vs-Female
2.142200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.668600E-01
Normal-vs-Age(41-60Yrs)
9.365000E-01
Normal-vs-Age(61-80Yrs)
6.170400E-01
Normal-vs-Age(81-100Yrs)
8.747200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.311400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.008200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.731000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.670100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.459600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.974800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.420200E-01
Normal-vs-Daily Drinker
7.629800E-01
Normal-vs-Weekly Drinker
9.836800E-01
Normal-vs-Occasional Drinker
9.818000E-01
Normal-vs-Social Drinker
8.754800E-01
Non Drinker-vs-Daily Drinker
3.859400E-01
Non Drinker-vs-Weekly Drinker
2.637200E-01
Non Drinker-vs-Occasional Drinker
2.196600E-01
Non Drinker-vs-Social Drinker
1.487190E-01
Daily Drinker-vs-Weekly Drinker
6.428600E-01
Daily Drinker-vs-Occasional Drinker
6.191400E-01
Daily Drinker-vs-Social Drinker
4.173200E-01
Weekly Drinker-vs-Occasional Drinker
9.976600E-01
Weekly Drinker-vs-Social Drinker
7.826800E-01
Occasional Drinker-vs-Social Drinker
7.656000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.790200E-01
Normal-vs-Grade 2
8.250400E-01
Normal-vs-Grade 3
7.365200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.758000E-03
Grade 1-vs-Grade 3
9.9941999999964E-05
Grade 1-vs-Grade 4
9.790200E-01
Grade 2-vs-Grade 3
4.187900E-02
Grade 2-vs-Grade 4
8.250400E-01
Grade 3-vs-Grade 4
7.365200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.072200E-01
Normal-vs-NonDiabetic
8.442800E-01
Diabetic-vs-NonDiabetic
2.461800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.084600E-01
Normal-vs-NoPancreatitis
7.124200E-01
Pancreatitis-vs-NoPancreatitis
2.290000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.040200E-01
Normal-vs-N1
7.895200E-01
N0-vs-N1
8.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.627600E-01
Normal-vs-TP53-NonMutant
6.282600E-01
TP53-Mutant-vs-TP53-NonMutant
6.05129999999843E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
